Unraveling the role of FGF21 in epilepsy disease: mechanistic insights and therapeutic Potential

This publication has 119 references indexed in Scilit:

• Fatty Acid Binding Protein 5 Mediates Astrocytic Pyroptosis and Neuroinflammation in Epilepsy via cGAS/STING Pathway
  Advanced Science, 2026
• Sex and gender-related differences in neurological diseases: current challenges and recommendations for clinical practice
  Neurological Sciences, 2026
• Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection
  Neuroprotection, 2024
• Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
  Archives of Toxicology, 2023
• Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions
  Journal of Molecular Medicine, 2022
• Factors not considered in the study of drug‐resistant epilepsy: Psychiatric comorbidities, age, and gender
  Epilepsia Open, 2022
• Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis
  Molecular Biology Reports, 2021
• High FGF‐21 level in a cohort of 22 patients with Dravet Syndrome—Possible relationship with the disease outcomes
  Epilepsia Open, 2021
• Expanding and validating the biomarkers for mitochondrial diseases
  Journal of Molecular Medicine, 2020
• Fibroblast growth factor (FGF21) protects mouse liver against d-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways
  Molecular and Cellular Biochemistry, 2015